Skip to main content

Table 4 Approaches of GPs in specific case scenarios (n = 88 a, n (%))

From: General practitioners’ approaches to prostate-specific antigen testing in the north-east of the Netherlands

Case scenario

Never

Rarely

Sometimes

Often

Always

PSA test in case of lower urinary tract symptoms

14 (17.3)

27 (33.3)

25 (30.9)

12 (14.8)

3 (3.7)

PSA test in case of unclear discomfort

10 (11.5)

16 (18.4)

40 (46.0)

18 (20.7)

3 (3.4)

DRE before PSA test

3 (3.4)

4 (4.5)

14 (15.9)

44 (50.0)

23 (26.1)

PSA test if DRE suggestive for prostate cancer

7 (8.0)

13 (14.8)

9 (10.2)

19 (21.6)

40 (45.5)

Case scenario

Yes

No

Are there situations where you would not refer a patient, having a PSA level ≥ 3 ng/mL, to a urologist?

80 (94.1)

5 (5.9)

If a patient has a normal PSA level, do you check the PSA level after some time again?

17 (20.2)

67 (79.8)

Did you perform a DRE on your last patient having lower urinary tract symptoms?

70 (82.4)

15 (17.6)

If a patient actively requests PSA screening, I will …

 perform a PSA test without explanation

1 (1.2)

 inform the patient on the (dis) advantages of the PSA test and order it

39 (45.9)

 inform the patient on the (dis) advantages of the test and make a new appointment to decide if to order one or not

30 (35.3)

 not order a PSA test

8 (9.4)

Others

7 (8.2)

  1. DRE Digital rectal examination, GP General practitioner, PSA Prostate-specific antigen, n/a Not applicable, a numbers (%) of participants. Numbers may not add up to total, due to missing values.